Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: Is the obesity paradox real?

Journal of Clinical Hypertension

Volumn 16, Issue 6, 2014, Pages 451-458

  Shah, Ravi V ^a   Abbasi, Siddique A ^b   Yamal, José Miguel ^c   Davis, Barry R ^c   Barzilay, Joshua ^d   Einhorn, Paula T ^e   Goldfine, Allison ^f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d Gwinnett Medical Center Duluth   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; ANTIHYPERTENSIVE AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; DYSGLYCEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IMPAIRED FASTING GLUCOSE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SMOKING; AGED; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TRENDS; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CAUSE OF DEATH; DOUBLE-BLIND METHOD; FASTING; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; SURVIVAL RATE; UNITED STATES;

EID: 84902325518     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12325     Document Type: Article

References (30)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127:e6-e245.
2. Strazzullo P, D'Elia L, Cairella G, et al. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke. 2010;41:e418-e426.
3. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
4. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167:1720-1728.
5. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-969.
6. Lloyd-Jones DM, Hong Y, Labarthe D, et al. American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613.
7. McGee DL; Diverse Populations Collaboration. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005;15:87-97.
8. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med. 2000;343:530-537.
9. Flegal KM, Kit BK, Graubard BI. Overweight, obesity, and all-cause mortality-reply. JAMA. 2013;309:1681-1682.
10. Barrett-Connor E, Khaw KT. Is hypertension more benign when associated with obesity? Circulation. 1985;72:53-60.
11. Carman WJ, Barrett-Connor E, Sowers M, Khaw KT. Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan. Circulation. 1994;89:703-711.
12. Willett WC, Hu FB, Thun M. Overweight, obesity, and all-cause mortality. JAMA. 2013;309:1681.
13. Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658-1667.
14. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640-1649.
15. Britton KA, Massaro JM, Murabito JM, et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol. 2013;62:921-925.
16. Yeboah J, Bertoni AG, Herrington DM, et al. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58:140-146.
17. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131-141.
18. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
19. de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA. 2001;285:2109-2113.
20. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition. 1997;13:65; discussion 64, 66.
21. Reaven GM, Strom TK, Fox B. Syndrome X: Overcoming the Silent Killer That Can Give You a Heart Attack. New York: Simon and Schuster; 2000:284.
22. Davis BR, Cutler JA, Gordon DJ, et al. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens. 1996;9:342-360.
23. Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233-244.
24. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308:581-590.
25. Heymsfield SB, Cefalu WT. Does body mass index adequately convey a patient's mortality risk? JAMA. 2013;309:87-88.
26. Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158:1855-1867.
27. Weber MA, Jamerson K, Bakris GL, et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet. 2013;381:537-545.
28. Wassertheil-Smoller S, Fann C, Allman RM, et al. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med. 2000;160:494-500.
29. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097-1105.
30. Mehta NK, Chang VW. Secular declines in the association between obesity and mortality in the United States. Popul Dev Rev. 2011;37:435-451.